BMA figures show cost of introducing STPs
About Richard Staines
Posts by Richard Staines:
Cancer drugs from Novartis and Pfizer also backed
Investors concerned over strong placebo effect
Attack overshadows surprise success for cholesterol drug
Concerns that NICE will reject Kisqali like it did Ibrance.
Seattle CEO hopes Adcetris will be standard of care.
Patients to get Santhera’s Raxone under EAMS scheme.